[go: up one dir, main page]

IL147774A0 - Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production - Google Patents

Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production

Info

Publication number
IL147774A0
IL147774A0 IL14777400A IL14777400A IL147774A0 IL 147774 A0 IL147774 A0 IL 147774A0 IL 14777400 A IL14777400 A IL 14777400A IL 14777400 A IL14777400 A IL 14777400A IL 147774 A0 IL147774 A0 IL 147774A0
Authority
IL
Israel
Prior art keywords
aminolactams
hydroxyalkanoyl
inhibitors
protein production
related structures
Prior art date
Application number
IL14777400A
Other languages
English (en)
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of IL147774A0 publication Critical patent/IL147774A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14777400A 1999-09-13 2000-09-13 Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production IL147774A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15351199P 1999-09-13 1999-09-13
US22438800P 2000-08-09 2000-08-09
PCT/US2000/024967 WO2001019797A2 (en) 1999-09-13 2000-09-13 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION

Publications (1)

Publication Number Publication Date
IL147774A0 true IL147774A0 (en) 2002-08-14

Family

ID=26850619

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14777400A IL147774A0 (en) 1999-09-13 2000-09-13 Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production

Country Status (9)

Country Link
EP (1) EP1212306A2 (es)
JP (1) JP2003509411A (es)
CN (1) CN1399634A (es)
AU (1) AU783914B2 (es)
BR (1) BR0014269A (es)
CA (1) CA2377221A1 (es)
IL (1) IL147774A0 (es)
MX (1) MXPA02001813A (es)
WO (1) WO2001019797A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
EP1265849B1 (en) 2000-03-23 2006-10-25 Elan Pharmaceuticals, Inc. Compounds and methods to treat alzheimer's disease
JP2004508289A (ja) 2000-04-03 2004-03-18 デュポン ファーマシューティカルズ カンパニー Aβタンパク質産生の阻害剤としての環状ラクタム
CA2404273A1 (en) * 2000-04-11 2001-10-18 Bristol-Myers Squibb Pharma Company Substituted lactams as inhibitors of a.beta. protein production
US6878363B2 (en) 2000-05-17 2005-04-12 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
GB0012671D0 (en) 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
WO2001092235A1 (en) 2000-06-01 2001-12-06 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
CA2410972A1 (en) 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
US6846813B2 (en) 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
BR0210721A (pt) 2001-06-27 2004-07-20 Elan Pharm Inc Composto, sal ou éster farmaceuticamente aceitável, método para fabricar um composto, e, método para tratar um paciente que tem, ou para evitar que o paciente adquira uma doença ou condição
EP1466898A4 (en) * 2001-12-27 2005-12-07 Daiichi Seiyaku Co INHIBITORS OF THE PRODUCTION / SEPARATION OF BETA-AMYLOIDS PROTEINS
WO2003094854A2 (en) 2002-05-07 2003-11-20 Elan Pharmaceuticals, Inc. Succinoyl aminopyrazoles and related compounds
TW200502221A (en) * 2002-10-03 2005-01-16 Astrazeneca Ab Novel lactams and uses thereof
EP1633350B1 (en) 2003-06-05 2012-10-03 Elan Pharmaceuticals, Inc. Acylated amino acid amidyl pyrazoles and related compounds
CA2676715A1 (en) 2007-02-12 2008-08-21 Merck & Co., Inc. Piperazine derivatives for treatment of ad and related conditions
EA017249B8 (ru) 2007-05-10 2013-01-30 Олбани Молекьюлар Рисерч, Инк. Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
DK2222636T3 (da) 2007-12-21 2013-06-03 Ligand Pharm Inc Selektive androgenreceptormodulatorer (SARMS) og anvendelser deraf
EP2291181B9 (en) 2008-04-18 2013-09-11 University College Dublin National University Of Ireland, Dublin Captodiamine for the treatment of depression symptoms
WO2015108988A2 (en) 2014-01-17 2015-07-23 Ligand Pharmaceuticals, Inc. Methods and compositions for modulating hormone levels
CN114096522A (zh) 2019-04-19 2022-02-25 利亘制药公司 化合物的晶型和制备化合物的晶型的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
CA2272065A1 (en) * 1996-11-22 1998-05-28 Thomas E. Mabry N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
AU749658C (en) 1996-12-23 2004-04-29 Elan Pharmaceuticals, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
CA2307221A1 (en) * 1997-12-22 1999-07-01 Elan Pharmaceuticals, Inc. Polycyclic .alpha.-amino-e-caprolactams and related compounds
JP2002518451A (ja) 1998-06-22 2002-06-25 エラン ファーマシューティカルズ,インコーポレイテッド 環状アミノ酸化合物およびその医薬組成物、並びにそれら化合物を用いたβ−アミロイドペプチドの放出および/またはその合成を阻害する方法
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
AU778005B2 (en) 1998-12-24 2004-11-11 Bristol-Myers Squibb Pharma Company Succinoylamino benzodiazepines as inhibitors of Abeta protein production

Also Published As

Publication number Publication date
AU7479700A (en) 2001-04-17
CA2377221A1 (en) 2001-03-22
WO2001019797A2 (en) 2001-03-22
EP1212306A2 (en) 2002-06-12
MXPA02001813A (es) 2004-03-19
WO2001019797A3 (en) 2002-04-11
BR0014269A (pt) 2002-07-02
CN1399634A (zh) 2003-02-26
JP2003509411A (ja) 2003-03-11
AU783914B2 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
IL147774A0 (en) Hydroxyalkanoyl aminolactams and related structures as inhibitors of as protein production
HUP0202705A3 (en) Methods and microorganisms or production of panto-compounds
IL149118A0 (en) Inhibitors of neuraminidases
IL142816A0 (en) SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
IL135261A (en) Footwear and its method of construction
GB0124299D0 (en) Crystal structure of enzyme and uses thereof
EP1539692A4 (en) FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
GB0015788D0 (en) Cutting elements and methods of manufacture thereof
PL339330A1 (en) Method of obtaining derivatives of quinazoline and novel intermediate compounds
HUP0200773A3 (en) Methods of inducing cacer cell death and tumor regression
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
AU3622600A (en) Metalloproteinases and methods of use therefor
PL339486A1 (en) Novel compounds - substituted 3-amino-3-aryl 1-propanols and method of obtaining them as well as therapeutic agent and method of obtaining same
GB9924334D0 (en) Pharmaceutical products and methods of fabrication therefor
HUP0202519A3 (en) Production of proteins
GB2359003B (en) Method of and line for breadcrumb production
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
DE60037236D1 (de) Wechselstromgenerator und dessen Herstellungsverfahren
AU3775500A (en) Setting of gemstones
PL340487A1 (en) Macaroni and method of making same
AU2001257253A1 (en) Asymmetric synthesis of piperazic acid and derivatives thereof
PL339487A1 (en) Novel compounds - substituted 3-amino-3-aryl 1-propanols and method of obtaining them as well as therapeutic agent and method of obtaining same
ITUD990143A0 (it) Procedimento di produzione di manufatti poliuretanici rivestiti e relativi manufatti
PL351128A1 (en) Method of obtaining phenoglycine and derivatives thereof
GB9920906D0 (en) Increased production of interferon-a